Exploring the role of tiny proteins in the immune system
Unraveling microprotein biology with an evolutionary-immunological framework
This study is looking at tiny proteins called microproteins to see how they work with our immune system, which could help us find new ways to treat autoimmune diseases and other health issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10925317 on NIH RePORTER |
What this research studies
This research investigates the function of microproteins, which are small proteins that have been largely overlooked in genetic studies. By examining how these microproteins evolve and their interactions with the immune system, the research aims to uncover their physiological relevance and potential roles in immune responses. The approach combines evolutionary biology with immunology to understand how these proteins may help the body respond to pathogens. Patients may benefit from insights gained about microproteins that could lead to new treatments for autoimmune diseases and other conditions.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with autoimmune diseases or those interested in the genetic factors influencing immune responses.
Not a fit: Patients with conditions unrelated to the immune system or those not affected by autoimmune diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for autoimmune diseases and enhance our understanding of immune responses.
How similar studies have performed: While the exploration of microproteins is a relatively novel area, previous research has shown that understanding protein evolution can lead to significant advancements in immunology.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Carvunis, Anne-Ruxandra — University of Pittsburgh at Pittsburgh
- Study coordinator: Carvunis, Anne-Ruxandra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.